Skip to main content
Premium Trial:

Request an Annual Quote

Opko to Buy Chilean Drug Firm for $16M in Cash

Premium

Opko Health last week announced that it has signed a definitive agreement to acquire Pharma Genexx, a privately held Chilean pharmaceutical firm, for $16 million in cash.

According to Opko, Pharma Genexx focuses on "the representation, importation, commercialization, and distribution of pharmaceutical products, [over-the-counter] products, and medical devices for the government, private, and institutional markets."

"We believe this acquisition to be an excellent strategic fit for Opko as we broadly expand into international markets," Opko Chairman and CEO Phillip Frost said in a statement. "We plan to extend the range of therapeutic areas covered by our products while maintaining a position in ophthalmology."

Additional terms of the transaction were not disclosed.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.